Nasdaq

Teleflex Receives FDA Clearance for Expanded Use of QuikClot Control+™ Hemostatic Device to Address All Grades of Bleeding

Teleflex Incorporated announced the FDA 510(k) clearance for an expansion of the QuikClot Control+™ Hemostatic Device's indications, now including all grades of internal and external bleeding.
Nasdaq

Teleflex receives FDA 510(k) Clearance for Expanded Indications of the QuikClot Control+™ Hemostatic Device

WAYNE, Pa., April 30, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced U.S. Food and Drug Administration (FDA) 510(k) ...
Seeking Alpha

Teleflex Receives FDA Clearance for Expanded Indication for QuikClot Control+™ Hemostatic Device Usage in Cardiac Surgical Procedures

WAYNE, Pa., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (TFX), a leading global provider of medical technologies, today announced the U.S Food and Drug Administration (FDA) has cleared the ...
HealthTech

Who Makes the Best Bleeding Control Kit?

Having the best bleeding control kit on hand can be a lifesaver when a critical medical emergency occurs. Whether you're an outdoor enthusiast, a first responder, or simply want to be prepared for ...